ArticleInternational journal of legal medicine2026
Archived medical specimens as antemortem DNA references for disaster victim identification, optimization study following the October 7 massacre.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The October 7, 2023 terrorist attack in Israel resulted in over 1,200 casualties, creating unprecedented disaster victim identification (DVI) challenges. Traditional ante-mortem (AM) reference methods using personal items proved insufficient as entire families were affected. We implemented a novel strategy utilizing archived medical specimens from Ministry of Health repositories to construct a self-direct-reference antemortem (AM) DNA database. This study systematically evaluates factors affecting STR profiling success from 151 archived clinical specimens (2003-2023): histological samples (FFPE blocks/cytology slides, n = 131), diagnostic swabs (n = 8), and blood/serum (n = 12). Four variables were assessed: tissue source, extraction method, incubation protocol, and sample age. DNA was amplified using Investigator 24plex Kit, success measured by informative autosomal STR loci obtained (maximum 21). Descriptive and non-parametric inferential statistical analyses were applied to compare profiling outcomes across variable conditions, confirming statistically significant differences between sample types and methods. This study demonstrates that archived medical specimens represent reliable, viable and valuable sources of AM references with success rates ranging from 67 to 100% of mean locus recovery (proportion), depending on tissue type and processing optimization. The findings emphasize the potential of these specimens especially when traditional materials are unavailable and providing actionable guidance for global DVI preparedness.
Indexed as
Identifiers
42814130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.